Type 1 insulin-like growth factor receptor (IGF-1R) expression has been detected in the plasma membrane and cytoplasm of chordoma cells and IGF-1R inhibition is considered a therapeutic target in chordoma [50]. The gene discussed is IGF1R; the disease is chordoma.